Bowel cancer screening less likely with low numeracy skills
the ONA take:
According to a new study published in the Journal of Health Psychology, those who have trouble understanding numbers may be less likely to undergo screening for bowel cancer, as well as being more likely to fear a negative result.
For the study, researchers asked people aged 45 to 59 to complete a questionnaire that evaluated their attitudes toward the bowel screening test and their numerical skills. For example, one question asked to identify whether 1 in 10, 1 in 100, or 1 in 1000 represents the greatest risk of developing a disease. About 46% of the 965 respondents got this question wrong.
Furthermore, respondents who were found to have lower numerical skills were more likely to believe that the test was disgusting or embarrassing, and more afraid of a negative result. These people also tended to understand less about the disease and were more likely ignore cancer information.
Specifically, respondents with low numerical skills were more likely to believe they did not need to be screened because they believed they were healthy and their physicians had not advised them to do so.
The findings of this study may help clinicians identify patients less likely to undergo a bowel cancer screening and to aid patients overcome barriers to prevent cancer or detect it early.
Those who have trouble understanding numbers may be less likely to undergo screening for bowel cancer.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|